KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) EBITDA: 2009-2024

Historic EBITDA for Bausch Health Companies (BHC) over the last 16 years, with Dec 2024 value amounting to $1.5 billion.

  • Bausch Health Companies' EBITDA rose 94.65% to $619.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 billion, marking a year-over-year increase of 40.52%. This contributed to the annual value of $1.5 billion for FY2024, which is 60.54% up from last year.
  • According to the latest figures from FY2024, Bausch Health Companies' EBITDA is $1.5 billion, which was up 60.54% from $963.0 million recorded in FY2023.
  • Over the past 5 years, Bausch Health Companies' EBITDA peaked at $1.5 billion during FY2024, and registered a low of $450.0 million during FY2021.
  • For the 3-year period, Bausch Health Companies' EBITDA averaged around $987.7 million, with its median value being $963.0 million (2023).
  • In the last 5 years, Bausch Health Companies' EBITDA soared by 433.00% in 2020 and then plummeted by 33.43% in 2021.
  • Over the past 5 years, Bausch Health Companies' EBITDA (Yearly) stood at $676.0 million in 2020, then crashed by 33.43% to $450.0 million in 2021, then rose by 0.89% to $454.0 million in 2022, then skyrocketed by 112.11% to $963.0 million in 2023, then skyrocketed by 60.54% to $1.5 billion in 2024.